| Active, not recruiting | 4 | 120 | US | Behavioral Treatment, Lifestyle modification, Behavioral weight loss, Lifestyle intervention, Placebo, Placebo for medication, Semaglutide 2.4 MG/0.75 ML Subcutaneous Solution [WEGOVY], Wegovy | University of Pennsylvania, Novo Nordisk A/S | Obesity | 07/25 | 07/25 | | |